COVID-19 outbreak, caused by severe acute respiratory syndrome (SARS)-CoV-2
coronavirus has become an urgent health and economic challenge. Diabetes is a risk factor …

Dipeptidyl-peptidase IV (DPP4), originally identified as an aminopeptidase in 1960s, is an
ubiquitously expressed protease presented as either a membrane-bound or soluble form …

The ongoing outbreak of the novel coronavirus pneumonia COVID-19 has caused great
number of cases and deaths, but our understanding about the pathogen SARS-CoV-2 …

Background. Sodium‐glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase‐4 (DPP‐4)
inhibitors are glucose‐lowering drugs whose anti‐inflammatory properties have recently …

CD26/Dipeptidyl peptidase 4 (DPP4) is a type II transmembrane glycoprotein that is widely
expressed in various organs and cells. It can also exist in body fluids in a soluble form …

Inflammation is implicated in the development and severity of the coronavirus disease 2019
(COVID-19), as well as in the pathophysiology of diabetes. Diabetes, especially when …

Our review summarizes the evidence that COVID-19 can be complicated by SARS-CoV-2
infection of immune cells. This evidence is widespread and accumulating at an increasing …

Many healthy people suffer from milk-related gastrointestinal discomfort (GID) despite not
being lactose intolerant; the mechanisms underpinning such condition are unknown. This …

Background The infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has rapidly spread all over the world, becoming pandemic. Several studies have shown …

Obesity is associated with an increase in morbidity and mortality from coronavirus disease
2019 (COVID-19). The risk is related to the cytokine storm, a major contributor to multiorgan …